Schlagwort: Luc Springinsfeld
Expecting more transactions
Over the past 24 months, we have seen a flurry of transactions in the life sciences tools space: Several high-growth companies providing novel research...
Healthcare Sector should profit from the corona crisis
From our interactions with the largest pharmaceutical companies, we understand that the impact of Covid-19 on healthcare is probably one of the smallest across...